Abstract:Fatty acid-binding proteins (FABPs) are small cytoplasmic proteins involved in intracellular lipid transport and bind free fatty acids, cholesterol, and retinoids. FABP3, the major neuronal FABP in the adult brain, is upregulated in the CSF of patients with Alzheimer's disease (AD). However, the precise role of neuronal FABPs in AD pathogenesis remains unclear. This study investigates the contribution of fabp, the Drosophila homolog of FABP3 and FABP7, to amyloid β (Aβ) pathology using a Drosophila model. Neuronal knockdown of fabp shortened the lifespan of flies and increased age-related protein aggregates in the brain. In an AD model, fabp knockdown in neurons increased Aβ accumulation and Aβ-induced neurodegeneration, whereas fabp overexpression ameliorated Aβ pathology. Notably, fabp overexpression stimulated autophagy, which was inhibited by the knockdown of Eip75B , the Drosophila homolog of the peroxisome proliferator-activated receptor (PPAR). The PPAR activator rosiglitazone restored autophagy impaired by fabp knockdown and reduced fabp knockdown-induced increased Aβ aggregation and cell death. Furthermore, knockdown of either fabp or Eip75B in the wing imaginal disc or adult fly brain reduced the expression of Atg6 and Atg8a . Additionally, treatment of the fabp knockdown AD model flies with polyunsaturated fatty acids, such as docosahexaenoic acid or linoleic acid, partially alleviated cell death in the developing eye, restored impaired autophagy flux, reduced Aβ aggregation, and attenuated Aβ-induced cell death. Our results suggest that Drosophila fabp plays an important role in maintaining protein homeostasis during aging and protects neurons from Aβ-induced cell death by enhancing autophagy through the PPAR pathway. These findings highlight the potential importance of neuronal FABP function in AD pathogenesis. Alzheimer's disease (AD) is a neurodegenerative disease characterized by a gradual progression to severe cognitive impairment and dementia. Despite its high heritability, only a limited number of genes associated with AD have been identified. Understanding the role of disease-associated genes is critical to unraveling the pathology of AD. Given the abnormal protein aggregation seen in AD, genes that affect the degradation of aggregated proteins are expected to be important players. In this study, we focused on FABP, a lipid transport protein that has been observed at elevated levels in the cerebrospinal fluid of patients with AD. The specific role of this protein in neurons affected by AD remained elusive. Using a Drosophila model of AD, we found that reduced expression of fabp in neurons increased accumulation of amyloid β (Aβ) and exacerbated Aβ-induced neurodegeneration. Conversely, overexpression of fabp attenuated these phenotypes. Our results confirm that the protective effect of fabp is mediated through autophagy. In particular, we identified the involvement of the nuclear receptor PPAR in this process. We also demonstrated that neuronal fabp plays a critical role in protein aggregation and lifespan during aging. In conclusion, our study highlights the critical role of neuronal FABP as a regulator in AD pathology and aging. These findings contribute to a better understanding of the molecular mechanisms underlying AD and open avenues for potential therapeutic interventions.

Neuronal fatty acid-binding protein enhances autophagy and suppresses amyloid-β pathology in a Drosophila model of Alzheimer's disease

Roles of Drosophila fatty acid-binding protein in development and behavior

P1-028: Overexpression of neprilysin reduces Abeta42-induced neuron loss and intraneuronal Abeta42 deposits, but causes age-dependent axon pathology in drosophila

Apolipoprotein E Induces Lipid Accumulation Through Dgat2 That Is Prevented with Time-Restricted Feeding in Drosophila

Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain

Lipophorin Receptors Genetically Modulate Neurodegeneration Caused by Reduction of Psn Expression in the Aging Drosophila Brain

Overexpression of Neprilysin Reduces Alzheimer Amyloid-Beta42 (Abeta42)-Induced Neuron Loss and Intraneuronal Abeta42 Deposits but Causes a Reduction in Camp-Responsive Element-Binding Protein-Mediated Transcription, Age-Dependent Axon Pathology, and Premature Death in Drosophila.

Glial Sphingosine-Mediated Epigenetic Regulation Stabilizes Synaptic Function in Drosophila Models of Alzheimer's Disease

Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer's disease

Nesfatin-1 ameliorates pathological abnormalities in Drosophila hTau model of Alzheimer's disease

Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila

Protein retention in the endoplasmic reticulum rescues Aβ toxicity in Drosophila

FABP7 Protects Astrocytes Against ROS Toxicity via Lipid Droplet Formation

Adipocyte metabolic state regulates glial phagocytic function

Degradation of Alpha-Synuclein by Dendritic Cell Factor 1 Delays Neurodegeneration and Extends Lifespan in Drosophila.

Fatty acid amide hydrolase gene inactivation induces hetero‐cellular potentiation of microglial function in the 5xFAD mouse model of Alzheimer's disease

Aging AdipoR2-deficient mice are hyperactive with enlarged brains excessively rich in saturated fatty acids

FABP7 upregulation induces a neurotoxic phenotype in astrocytes

Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer's Disease Model

Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing